| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Income (loss) before income taxes | -26,324 | 297,868 | 238,089 | 134,441 |
| Provision for income taxes | 4,420 | 57,336 | 52,403 | 28,361 |
| Net income (loss) | -30,744 | 240,532 | 185,686 | 106,080 |
| Earnings (loss) per share, basic (in dollars per share) | -0.16 | 1.25 | 0.97 | 0.56 |
| Earnings (loss) per share, diluted (in dollars per share) | -0.16 | 1.23 | 0.95 | 0.55 |
| Weighted average common shares outstanding, basic (in shares) | 192,032,000 | 191,907,000 | 190,967,000 | 190,429,000 |
| Weighted average common shares outstanding, diluted (in shares) | 192,032,000 | 197,091,000 | 196,474,000 | 197,147,000 |
BIOMARIN PHARMACEUTICAL INC (BMRN)
BIOMARIN PHARMACEUTICAL INC (BMRN)